SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-039686
Filing Date
2015-05-06
Accepted
2015-05-06 21:24:42
Documents
2
Period of Report
2015-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3529
2 EX-24 DOCUMENT attachment1.htm EX-24 2174
  Complete submission text file 0001209191-15-039686.txt   7226
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tibira Therapeutics, Inc. (Issuer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Jenkins Helen (Reporting) CIK: 0001614739 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35953 | Film No.: 15839117